The Government Assault Against Ivermectin and other Safe SARS-2 Treatments
Richard Gale and Gary Null PhD
Progressive Radio Network, September 1, 2021
Had the FDA and Anthony Fauci’s National Institute for Allergies and Infectious Disease (NIAID) started approving existing clinically-proven and inexpensive drugs for treating malaria, parasites and other pathogens at the start of the pandemic, millions of pe...
The Government Assault Against Ivermectin and other Safe SARS-2 Treatments
Richard Gale and Gary Null PhD
Progressive Radio Network, September 1, 2021
Had the FDA and Anthony Fauci’s National Institute for Allergies and Infectious Disease (NIAID) started approving existing clinically-proven and inexpensive drugs for treating malaria, parasites and other pathogens at the start of the pandemic, millions of people would have been saved from experiencing serious infections or dying from the SARS-CoV-2 virus. Why federal health officials never followed this strategy is a question the mainstream media refuses to ask.
Another question that the medical establishment, let alone our compliant media, is why have they failed to ask whether there are reliable studies in the peer-reviewed literature and testimonies from thousands of day-to-day clinical physicians worldwide who treat Covid-19 patients with these drugs, in particular hydroxychloroquine (HCQ) and Ivermectin. We may also point out the many different natural remedies, such as nigella sativa, curcumin, vitamin D, melatonin, etc, which have been shown to be effective against SARS-2 infections. In most nations, there has been enormous success in treating Covid patients at the early and moderate stages of infection. However, in the US, Anthony Fauci, Bill Gates, the FDA and our federal medical officials have categorically denied their use. In fact during the past couple weeks, there has been an aggressive and concerted effort to erect obstacles to prevent the employment of these more effective drugs. More recently a widespread campaign is underway to denigrate them altogether.
For example, the TOGETHER trial is now touted by the mainstream media as a flagship study showing that ivermectin is ineffective and even dangerous to prescribe. The study was conducted by professor Edward Mills at McMaster University in Ontario. If we are to believe the New York Times, the trial, which enrolled 1,300 patients, was discontinued because Mills claimed the drug was no better than a placebo. However, there is strong reason to believe this entire trial was nothing less than a staged theatrical performance. When asked, Mills denied having any conflict of interests. However, Mills happens to be employed as a clinical trial advisor for the Bill and Melinda Gates Foundation. The Gates Foundation was also the trial’s principal funder. It may be noted that various organizations and agencies in other nations, such as the Health Products Regulatory Authority in South Africa, which have banned ivermectin, are often funded by Gates. It is naïve to believe that Gates has any philanthropic intentions whatsoever to see a highly effective treatment for SARS-2 infections reach worldwide approval. These drugs are in direct competition to his enormous investments and unwavering commitment to the Covid-19 vaccines.
In the meantime, Americans only have monoclonal antibody therapy and the controversial and ineffective drug Remdesivir at their disposal. Remdesivir’s average effectiveness for late stage treatment is only 22 percent. A Chinese study published in The Lancet found no statistically significant benefit in the drug and 12 percent of participants taking the drug had to discontinue treatment due to serious adverse effects, especially liver and kidney damage.
When questions are posited as a general argument for advocating expedient measures to protect public health during this pandemic, would it not have been wise to have prioritized for emergency use HCQ, Ivermectin, and other remedies with a record of curtailing Covid, such as the antibiotic azithromycin, zinc, selenium, Vitamins C and D, and melatonin as a first line of defense? There was absolutely no need to have waited for experimental vaccines or experimental drugs such as Remdesivir before the pandemic became uncontrollable. But this is what Fauci and Trump, and now Biden, permitted to happen.
If this strategy of medical intervention had been followed, would it have been successful? The answer is likely an unequivocal “yes”. Both HCQ and, even better, Ivermectin have been prophylactically prescribed by physicians working on pandemic’s front lines with enormous success. Yet those American physicians struggling to get this urgent message out to federal health officials are being marginalized and ridiculed en masse. Only in the US, the UK, France, South Africa and several other developed nations has there been a stubborn hubris to deny their effectiveness. The World Health Organization recommends Ivermectin for Covid-19 so why not the US and these other nations? Under oath, multiple physicians and professors at American medical schools have testified before Congress to present the scientific evidence supporting HCQ and Ivermectin. These are otherwise medical professionals at the very heart of treating Covid-19 patients.
Today, American journalism is in shambles. In fact, it is a disgrace. The American public is losing trust in the media. Whether it is CNN, the New York Times, the Washington Post, the liberal tabloid Daily Beast, NPR or PBS, each has unlimited resources to properly investigate the federal and institutional machinery behind the government health policies being thrust upon us. Yet no mainstream journalist has found the moral compass to bring this truth to the public.
In the meantime, we are allowing millions to die, and countless others to be seriously affected from a severe infection because of professional medical neglect and a healthcare system favoring the pharmaceutical industry’s frantic rush to develop expensive novel drugs and experimental vaccines. The incentive by the drug makers is to take every advantage available within the FDA’s emergency use loopholes to get their products approved as quickly as possible. The primary advantage is that these novel drugs and vaccines can then leap over regulatory hurdles, which otherwise would require them to conduct lengthy and thorough clinical trials to prove their efficacy and safety. The consequence is that none of the new pharmaceutical Covid-19 interventions have been adequately reviewed.
On the other hand, HCQ and Ivermectin have an established legacy of prior research and have been on the market for decades. Worldwide, it is not unreasonable to claim that billions of people have been treated with these drugs.
Below is a breakdown of the studies conducted so far for HCQ, Ivermectin and Vitamin D specifically for combatting the SARS-CoV-2 virus
Hydroxychloroquine
344 studies, 250 peer-reviewed have been conducted specifically for Covid-19
281 have been clinical trials that involved 4,583 scientists and over 407,627 patients
64% improvement in 31 early treatment trials
75% improvement in 13 early stage infection treatment mortality results
21% improvement in 190 late stage infection treatment trials (patients in serious condition)
23% improvement in 44 randomized controlled trials
Full list of HCQ studies and details: https://c19hcq.com
Ivermectin
131 studies, 52 peer-reviewed have been conducted specifically for Covid-19
63 have been clinical trials that involved 613 scientists and over 26,398 patients
58% improvement in 31 randomized controlled trials
86% improvement in 14 prophylaxis trials
72% improvement in 27 early stage infection treatment trials
40% improvement in 22 late stage infection treatment trials
58% improvement in 25 mortality results
Full list of Ivermectin studies and details: https://c19ivermectin.com
Other inexpensive repurposed drugs for treating SARS-2
Fluvoxamine
88% improvement in early treatment
29% improvement in late stage treatment
63% improvement in all 7 peer-reviewed studies
Vitamin D
101 studies conducted by over 875 scientists
63 sufficiency studies with 34,863 patients
33 treatment trials with 46,860 patients
42% improvement in 33 treatment trials
56% improvement in 68 sufficiency studies
55% improvement in 19 treatment mortality results
Full list of Vitamin D studies and details: https://c19vitamind.com
In contrast there have been 21 studies enrolling 35,744 patients in Remdesivir trials showing only a 22% improvement in all studies combined. This rate is below that of simply taking probiotics (5 studies at 24% improvement), melatonin (7 studies at 62% improvement), curcumin (4 studies at 71% improvement), nigella sativa (3 studies at 84% improvement), quercetin (4 studies at 76% improvement), and aspirin (7 studies at 37% improvement). Despite the small number of trials and low numbers of enrolled participants, early results indicate that greater attention and funding needs to be allocated for more rigorous research if there is to be any success in curbing SARS-2 infections’ severity.
Please share this information. The inept policies and measures being taken by our federal health officials and by both the former Trump and present Biden administrations are unparalleled in American healthcare history. And never before has the media been so willing to self-censor and been so grossly irresponsible to hide the published science and the truth.
